Skip to main content
MON.MIBG ¹³¹I- Therapeutic
Therapeutic IV Solution for Injection

Used for the local, lesion-specific treatment of neuroectodermal / neuroendocrine tumors, in particular pheochromocytoma, neuroblastoma, paraganglioma, medullar thyroid carcinoma, and carcinoid tumor.

 
Content

(131I) iobenguane sulfate solution for injection

 
 
Shelf-Life

4 days after the manufacturing date.

Definition

MIBG I131 Therapeutic is a radiopharmaceutical solution to be administered as intravenous infusion.